Recent Norepinephrine Current Events | Norepinephrine News
|
|
|
Sort By:
Relevance | Page Views |
New Down syndrome treatment suggested by Stanford/Packard study in mice
At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. view more (2009-11-19)
Cognitive dysfunction reversed in mouse model of Down syndrome
A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. view more (2009-11-19)
Fine-tuning treatments for depression
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may help fine-tune therapies for depression. view more (2009-10-19)
Antidepressants: benefit of SNRI is proven
The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to investigate whether patients with depression benefit from taking drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) drug class. view more (2009-08-26)
Researchers unravel mystery behind long-lasting memories
A new study by researchers at Wake Forest University School of Medicine may reveal how long-lasting memories form in the brain. view more (2009-08-12)
Genetic marker linked to problem behaviors in adults with developmental disabilities
A common variation of the gene involved in regulating serotonin and norepinephrine in the brain may be linked to problem behaviors in adults with developmental and intellectual disabilities, new research indicates. view more (2009-07-22)
UCLA scientists present first genetic evidence for why placebos work
Placebos are a sham - usually mere sugar pills designed to represent "no treatment" in a clinical treatment study. The effectiveness of the actual medication is compared with the placebo to determine if the medication works. view more (2009-07-21)
Mouse model of Parkinson's reproduces nonmotor symptoms
The classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements. Over the last decade, neurologists have been paying greater attention to non-motor symptoms, such as digestive and sleep problems, loss of sense of smell and depression. view more (2009-06-23)
Gene test determines risk of heart surgery complications
Genetic differences can explain why some patients undergoing heart surgery later experience shock and kidney complications. view more (2009-05-01)
'Mirthful Laughter,' Coupled With Standard Diabetic Treatment, Raises Good Cholesterol And May Lower Heart Attack Risk
The connection between the body, mind and spirit has been the subject of conventional scientific inquiry for some 20 years. The notion that psychosocial and societal considerations have a role in maintaining health and preventing disease became crystallized as a result of the experiences of a layman, Norman Cousins. In the 1970s, Cousins, then a... view more... (2009-04-17)
Georgia State researchers shed light on fat burning
Researchers at Georgia State University have found that fat cells give feedback to the brain in order to regulate fat burning much the same way a thermostat regulates temperature inside a house. view more (2009-02-06)
'Warrior Gene' Predicts Aggressive Behavior After Provocation
Individuals with the so-called "warrior gene" display higher levels of aggression in response to provocation, according to new research co-authored by Rose McDermott, professor of political science at Brown University. view more (2009-01-21)
Voluntary exercise does not appear to alleviate anxiety and depression
Voluntary physical activity does not appear to cause a reduction in anxiety and depression, but exercise and mood may be associated through a common genetic factor, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. view more (2008-08-05)
Comparison of venlafaxine and SSRIs in the treatment of depression
There are numerous antidepressant medications currently on the market, but sadly, many patients still experience the debilitating symptoms of depression even with treatment. view more (2008-02-22)
Cocaine's effects on brain metabolism may contribute to abuse
Many studies on cocaine addiction - and attempts to block its addictiveness - have focused on dopamine transporters, proteins that reabsorb the brain's "reward" chemical once its signal is sent. view more (2008-02-19)
Venlafaxine extended-release effective for patients with major depression
Major depressive disorder (MDD) is the most common major mental illness, afflicting almost one in five individuals. More than 75% of people who recover from an episode of MDD will have at least one recurrence, with the majority having multiple recurrences. view more (2007-12-13)
Study shows new strategy for developing antidepressants
Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect, according to a new study presented at the American College of Neuropsychopharmacology (ACNP) annual... view more... (2007-12-10)
Septic survival
While survival rates for sepsis have increased over the past two decades, children under four and those in adolescence remain highly susceptible to the condition. view more (2007-10-18)
What emotional memories are made of
Both extensive psychological research and personal experiences confirm that events that happen during heightened states of emotion such as fear, anger and joy are far more memorable than less dramatic occurrences. view more (2007-10-05)
Treating depression may improve recovery of heart rate variability following coronary syndromes
Patients with depression appear to have an impaired ability to recover their heart rate variability following acute coronary syndromes such as heart attack, a factor that could increase their risk of coronary death. view more (2007-09-04)
|
|
|
|
Sort By:
Relevance | Page Views |
|
